Warm Lidocaine/Tetracaine Patch Versus Placebo Before Pediatric Intravenous Cannulation: A Randomized Controlled Trial
To access this article, please choose from the options below
Supervising editor: Steven M. Green, MD
Author contributions: AJS conceived the study and designed the trial. AJS and BRT supervised the conduct of the trial and data collection. ENC, NG, and JC undertook recruitment of participating patients and managed the data, including quality control. AJS drafted the article, and all authors contributed substantially to its revision. AJS takes responsibility for the paper as a whole.
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. The lidocaine/tetracaine and placebo patches were supplied free of charge by the makers of Synera, Endo Pharmaceuticals, Chadds Ford, PA.
Publication dates: Available online April 8, 2008.
Reprints not available from the authors.
PII: S0196-0644(08)00428-9
doi:10.1016/j.annemergmed.2008.01.336
© 2008 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
